PURPOSE: This study compared performance of the Atlas io polymerase chain reaction-based, point-of-care (POC) assay for Chlamydia trachomatis (CT), to Aptima Combo 2, a standard of care nucleic acid amplification assay, and evaluated patient attitudes toward POC testing. METHODS: Women 14 years or older undergoing CT screening/testing were recruited from Teen Health Center and a sexually transmitted disease clinic. Participants provided self-obtained vaginal swabs for testing with the Atlas io and Aptima Combo 2, and completed questionnaires assessing attitudes toward POC testing. RESULTS: Of 296 women recruited, 284 (192 from sexually transmitted disease clinic, 92 from Teen Health Center) had Aptima Combo 2 and Atlas io results available; 273 completed the questionnaire. Average age was 27.4 years (SD, 10.8 years). Sensitivity and specificity of the Atlas io test were 83.9% (26/31 specimens; 95% confidence interval [CI], 70.9-96.8%) and 98.8% (250/253 specimens; 95% CI, 97.5-100%), respectively. When specimens with discrepant results were included in the analyses, adjudicated sensitivity and specificity were 92.9% (26/28 specimens; 95% CI, 83.3 to 100%) and 98.8% (253/256 specimens; 95% CI, 97.5 to 100%), respectively.A majority (70%) of women preferred to collect vaginal self-swab if a POC test were available. Most (61%) were willing to wait up to 20 minutes, and 26% were willing to wait up to 40 minutes for results, if they could be treated before leaving clinic. CONCLUSIONS: A POC polymerase chain reaction test detecting CT had high sensitivity and specificity when testing prospective, vaginal swab samples. Availability of CT results during patients' visits may decrease time to treatment.
PURPOSE: This study compared performance of the Atlas io polymerase chain reaction-based, point-of-care (POC) assay for Chlamydia trachomatis (CT), to Aptima Combo 2, a standard of care nucleic acid amplification assay, and evaluated patient attitudes toward POC testing. METHODS:Women 14 years or older undergoing CT screening/testing were recruited from Teen Health Center and a sexually transmitted disease clinic. Participants provided self-obtained vaginal swabs for testing with the Atlas io and Aptima Combo 2, and completed questionnaires assessing attitudes toward POC testing. RESULTS: Of 296 women recruited, 284 (192 from sexually transmitted disease clinic, 92 from Teen Health Center) had Aptima Combo 2 and Atlas io results available; 273 completed the questionnaire. Average age was 27.4 years (SD, 10.8 years). Sensitivity and specificity of the Atlas io test were 83.9% (26/31 specimens; 95% confidence interval [CI], 70.9-96.8%) and 98.8% (250/253 specimens; 95% CI, 97.5-100%), respectively. When specimens with discrepant results were included in the analyses, adjudicated sensitivity and specificity were 92.9% (26/28 specimens; 95% CI, 83.3 to 100%) and 98.8% (253/256 specimens; 95% CI, 97.5 to 100%), respectively.A majority (70%) of women preferred to collect vaginal self-swab if a POC test were available. Most (61%) were willing to wait up to 20 minutes, and 26% were willing to wait up to 40 minutes for results, if they could be treated before leaving clinic. CONCLUSIONS: A POC polymerase chain reaction test detecting CT had high sensitivity and specificity when testing prospective, vaginal swab samples. Availability of CT results during patients' visits may decrease time to treatment.
Authors: Johan H Melendez; Jill S Huppert; Mary Jett-Goheen; Elizabeth A Hesse; Nicole Quinn; Charlotte A Gaydos; Chris D Geddes Journal: J Clin Microbiol Date: 2013-06-26 Impact factor: 5.948
Authors: Jill S Huppert; Elizabeth A Hesse; Molly A Bernard; Yang Xiao; Bin Huang; Charlotte A Gaydos; Jessica A Kahn Journal: Sex Transm Infect Date: 2011-07-27 Impact factor: 3.519
Authors: J A Kahn; D I Bernstein; S L Rosenthal; B Huang; L M Kollar; J L Colyer; A M Tissot; P A Hillard; D Witte; P Groen; G B Slap Journal: Sex Transm Infect Date: 2005-10 Impact factor: 3.519
Authors: Kaitlyn R Rivard; Lisa E Dumkow; Heather M Draper; Kasey L Brandt; David W Whalen; Nnaemeka E Egwuatu Journal: Diagn Microbiol Infect Dis Date: 2016-10-18 Impact factor: 2.803
Authors: Jennifer L Reed; Lauren Simendinger; Sarah Griffeth; Hye Grace Kim; Jill S Huppert Journal: J Adolesc Health Date: 2009-10-12 Impact factor: 5.012
Authors: Yu-Hsiang Hsieh; M Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill Huppert; Anne M Rompalo; Charlotte A Gaydos Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240
Authors: Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook Journal: J Clin Microbiol Date: 2013-03-06 Impact factor: 5.948
Authors: Katherine M E Turner; Jeff Round; Patrick Horner; John Macleod; Simon Goldenberg; Arminder Deol; Elisabeth J Adams Journal: Sex Transm Infect Date: 2013-11-22 Impact factor: 3.519
Authors: William M Geisler; Jane S Hocking; Toni Darville; Byron E Batteiger; Robert C Brunham Journal: Clin Infect Dis Date: 2022-04-13 Impact factor: 9.079
Authors: Alexander Y Trick; Johan H Melendez; Fan-En Chen; Liben Chen; Annet Onzia; Aidah Zawedde; Edith Nakku-Joloba; Peter Kyambadde; Emmanuel Mande; Joshua Matovu; Maxine Atuheirwe; Richard Kwizera; Elizabeth A Gilliams; Yu-Hsiang Hsieh; Charlotte A Gaydos; Yukari C Manabe; Matthew M Hamill; Tza-Huei Wang Journal: Sci Transl Med Date: 2021-05-12 Impact factor: 17.956